UPDATE 1-Sage's seizure drug fails key trial, shares slump 5:24 AM health No comments UPDATE 1-Sage's seizure drug fails key trial, shares slump Reuters Sage's epilepsy drug fails to do better than placebo in key clinical trial STAT Sage Therapeutics: Brexanolone STATUS Trial Fails To Achieve Primary Endpoint NasdaqFull coverage Share It Facebook Twitter LinkedIn BLOG AUTHOR Please add Follow him @ Linkedin | Instagram | Twitter
0 comments:
Post a Comment
Note: Only a member of this blog may post a comment.